← Back to catalogue

Shoulder Innovations Inset Reverse Total Shoulder

FDA UDI

Class II (US FDA UDI)

by SHOULDER INNOVATIONS, Inc

Identity

Trade Name
Shoulder Innovations Inset Reverse Total Shoulder FDA UDI
Generic Name
Total shoulder prosthesis FDA UDI
Device Name
Shoulder Innovations Inset Reverse Total Shoulder - Posterior Retractor for help in holding back soft tissue during surgery FDA UDI
Model / Reference
MTO Posterior Retractor FDA UDI
Description
Shoulder Innovations Inset Reverse Total Shoulder - Posterior Retractor for help in holding back soft tissue during surgery FDA UDI

Identifiers

Catalog Number
2N1RT00001 FDA UDI
Primary DI / UDI-DI
B1132N1RT000010 FDA UDI
FDA Product Code
MBF FDA UDI
PHX FDA UDI
GMDN Term
Total shoulder prosthesis FDA UDI

Classification

Device Class
Class II FDA UDI
Regulation Number
888.3670 FDA UDI
888.3660 FDA UDI
Commercial Distribution
In Commercial Distribution FDA UDI

Clinical & Handling

Sterile

No

FDA UDI

Single Use

No

FDA UDI

Implantable

Yes

FDA UDI

Contains Latex

No

FDA UDI

Prescription Use

Yes

FDA UDI

Over-the-Counter

No

FDA UDI

Convenience Kit

No

FDA UDI

Combination Product

No

FDA UDI

HCT/P

No

FDA UDI

Premarket Exempt

No

FDA UDI

Lot / Batch Number

Yes

FDA UDI

Serial Number

No

FDA UDI

Expiration Date

No

FDA UDI

Manufacturing Date

No

FDA UDI
Sterilization Method
Moist Heat or Steam Sterilization FDA UDI

Category: Orthopaedic prosthesis implantation positioning instrument, reusableTotal reverse shoulder prosthesisTotal shoulder prosthesis

Shoulder Innovations Inset Reverse Total Shoulder by SHOULDER INNOVATIONS, Inc — Class II — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS

Similar devices

Also classified as Total shoulder prosthesis.

Authorization Coverage (1 country)

Regulatory Authorizations

United States Pending data

FDA UDI

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Sources (1)

  • FDA UDI ce0a5aac-9283-47d7-aa48-0601d90d3699 35 fields · synced May 30, 2026